BLC
MRK icon

Brown, Lisle/Cummings’s Merck MRK Stock Holding History

Brown, Lisle/Cummings’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.98M Buy
33,073
+186
+0.6% +$21.5K 0.99% 24
2025
Q4 		$3.46M Buy
32,887
+227
+0.7% +$21.3K 0.85% 31
2025
Q3 		$2.74M Sell
32,660
-425
-1% -$35K 0.7% 38
2025
Q2 		$2.62M Sell
33,085
-2,330
-7% -$185K 0.7% 40
2025
Q1 		$3.18M Buy
35,415
+1,233
+4% +$115K 0.92% 28
2024
Q4 		$3.4M Buy
34,182
+1,995
+6% +$206K 1.01% 24
2024
Q3 		$3.66M Buy
32,187
+1,250
+4% +$149K 1.11% 23
2024
Q2 		$3.83M Buy
30,937
+2,074
+7% +$267K 1.25% 19
2024
Q1 		$3.81M Sell
28,863
-25
-0.1% -$3.08K 1.29% 20
2023
Q4 		$3.15M Buy
28,888
+8,974
+45% +$932K 1.17% 22
2023
Q3 		$2.05M Buy
19,914
+419
+2% +$45.2K 0.93% 26
2023
Q2 		$2.25M Buy
19,495
+2,895
+17% +$329K 1.01% 23
2023
Q1 		$1.77M Sell
16,600
-960
-5% -$104K 0.9% 27
2022
Q4 		$1.95M Buy
17,560
+548
+3% +$56K 1.05% 25
2022
Q3 		$1.47M Buy
17,012
+100
+0.6% +$8.93K 0.86% 32
2022
Q2 		$1.54M Sell
16,912
-657
-4% -$58.2K 0.85% 32
2022
Q1 		$1.44M Buy
17,569
+320
+2% +$25.2K 0.69% 39
2021
Q4 		$1.32M Buy
+17,249
New +$1.37M 0.66% 41

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown, Lisle/Cummings's MRK Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Merck (MRK) stake by 0.57% in Q1 2026, buying an estimated $21.5K and bringing the position to 33,073 shares worth $3.98M. The position accounts for 0.99% of the portfolio, ranked #24.

Brown, Lisle/Cummings first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Brown, Lisle/Cummings held 33,073 shares of Merck worth $3.98M as of Q1 2026.
  • Brown, Lisle/Cummings bought 186 Merck shares in Q1 2026, an estimated $21.5K.
  • Merck made up 0.99% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #24 holding.
  • Brown, Lisle/Cummings first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.